Cerevel Therapeutics Hldg (NASDAQ:CERE) reported its Q1 earnings results on Tuesday, May 10, 2022 at 06:30 AM.
Here's what investors need to know about the announcement.
Earnings
Cerevel Therapeutics Hldg missed estimated earnings by 9.52%, reporting an EPS of $-0.46 versus an estimate of $-0.42.
Revenue was down $0.00 from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.01 which was followed by a 6.45% increase in the share price the next day.
To track all earnings releases for Cerevel Therapeutics Hldg visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
